Skinovative(R) Announces a Safe Non-Surgical Liposuction Alternative With the Launch...

* Reuters is not responsible for the content in this press release.

Tue Jul 7, 2009 9:43am EDT

Skinovative(R) Announces a Safe Non-Surgical Liposuction Alternative With the
Launch of Zerona(TM) Laser.

HOUSTON, July 7 /PRNewswire/ -- Skinovative(R), one of the country's premier
aesthetic medical facilities, has just added the newest FDA approved
non-invasive body contouring procedure, the Zerona(TM) Laser, to their list of
treatment options. 

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090707/DA42438LOGO)

The Zerona(TM) is a low-level laser designed to remove fat and contour the
body without invasive surgery. Recent clinical studies which tracked the
circumferences of patient's waist, hips, and thighs, showed total reduction
ranging from 3 to 9 inches with an average of 5 to 6 six inches, in just 2
weeks.

The Zerona(TM) laser is a hot topic in the cosmetic industry; it has been
featured on CBS's "The Doctors" and several regional news channels. Dr. Drew
Ordon, lead physician on "The Doctors" recently said, "When something sounds
too good to be true, it usually is. But you cannot argue with the results.
Inches are inches, and the Zerona(TM) removes inches, more than seven inches
on the 'test' case we did for The Doctors. I have to say, I didn't believe it
at first either."  

Dr. Michael Gomez of Skinovative(R) explains, "Unlike liposuction, and in
contrast to high-power, high-heat devices that melt fat, the new Zerona(TM)
laser produces a low-level, or 'cold', output that has no thermal effect on
the body's tissue. Instead, the non-invasive laser stimulates a biological
reaction in the fat cells causing them to liquefy and discharge their
contents. The excess fat is then processed by the lymphatic system and
excreted through the body's natural processes, without any negative side
effects."

Skinovative(R) director Chris Bailey said, "The procedure could not be easier,
during treatment the Zerona(TM) shines it's five low level lasers onto the
desired areas. Clients simply relax comfortably, listen to music, work on
their blackberry, or take a nap. The laser light is visible, but there is no
sensation during or after the treatment. Since no recovery time is needed,
clients are able to resume normal activities immediately."

Bailey went on to say, "Zerona(TM) clients are treated six times over two
weeks. Each of the six sessions takes 40 minutes. Treatment is delivered 20
minutes to the front of the body and 20 minutes to the back of the body.
Clients are able to have the front and back of their waist, hips, and thighs
treated all at the same time, or focus on one or other areas."

Dr. Gomez said, "In addition to making a person look better, the new
Zerona(TM) treatment may also make them healthier. While the treatment is not
yet FDA-cleared for that purpose, blood tests performed before and after the
procedure during the clinical trials have suggested some improvement in
cholesterol and triglyceride levels."

Dr. Gomez added, "The Zerona(TM) is not a weight loss program, or a substitute
for a healthy lifestyle. It is a great way to slim stubborn problem areas, and
can be a 'jump-start' to a person's slimming efforts or as motivation for
maintaining a healthier lifestyle."

About Skinovative(R) Houston
Skinovative(R), conveniently located in Houston's Galleria mall next to
Nordstrom, is a state-of-the art aesthetic facility for men and women. The
facility, with 5 comfortable procedure rooms includes the latest advanced
technologies in non-invasive body contouring, medical weight loss, laser skin
rejuvenation, laser hair removal, skin tightening, as well as standards like
BOTOX(R) Cosmetic, and many other aesthetic treatments. 

For more information visit, www.MyZeronaHouston.com or
www.SkinovativeHouston.com To reach Skinovative(R) or to set up a consultation
call (713) 482-2370.



SOURCE  Skinovative

Chris Bailey of Skinovative, +1-713-482-2370
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.